all other clinical laboratory parameters (hematology, serum chemistry, and urinalysis) within normal limits or not clinically significant
ECG normal, or abnormalities not clinically significant
surgically sterile, postmenopausal, or using adequate contraception and have a negative pregnancy test at Screening
willing and able to sign an informed consent form
You may not be if
diagnosed with type 1 diabetes mellitus or has a history of ketoacidosis
treatment with insulin, TZDs (excluding rosiglitazone) or any other oral or injected antidiabetic (excluding metformin or Avandamet) within 3 months prior to screening or during study treatment
change in lipid-lowering medication within 2 months of screening
taken systemic corticosteroids within 1 month prior to screening or during study treatment
history of or current/active cardiovascular disease
significant current pulmonary conditions
significant thyroid disease
CPK value \> 3x ULN
a female who is pregnant or lactating
systolic BP \> 160 mm Hg or a diastolic BP \> 90 mm Hg at screening
previous or current history of cancer, other than basal cell or stage 1 squamous cell carcinoma of the skin, that has not been in remission within 5 years prior to randomization
liver function tests (ALT, AST, ALP) \> 2 times ULN, or active liver disease at screening
history of positive HIV
positive hepatitis B test at screening
weight loss or gain \>/= 15 lbs within 3 months of screening
history of substance abuse (including alcohol abuse) within 2 years prior to screening
donated and/or received any blood or blood products within 3 months prior to randomization
taken an investigational study medication within 30 days prior to screening or during the study
